Cargando…

Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study

Multi-systemic biological risk (MSBR), a proxy for allostatic load, is a composite index of biomarkers representing dysregulation due to responses to chronic stress. This study examined the association of an MSBR index with cancer mortality. The sample included n = 13,628 adults aged 20–90 from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Acheampong, Teofilia, Jiang, Luohua, Ziogas, Argyrios, Odegaard, Andrew O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081240/
https://www.ncbi.nlm.nih.gov/pubmed/32193496
http://dx.doi.org/10.1038/s41598-020-61945-9
_version_ 1783508136776171520
author Acheampong, Teofilia
Jiang, Luohua
Ziogas, Argyrios
Odegaard, Andrew O.
author_facet Acheampong, Teofilia
Jiang, Luohua
Ziogas, Argyrios
Odegaard, Andrew O.
author_sort Acheampong, Teofilia
collection PubMed
description Multi-systemic biological risk (MSBR), a proxy for allostatic load, is a composite index of biomarkers representing dysregulation due to responses to chronic stress. This study examined the association of an MSBR index with cancer mortality. The sample included n = 13,628 adults aged 20–90 from the NHANES III Linked Mortality File (1988–1994). The MSBR index included autonomic (pulse rate, blood pressure), metabolic (HOMA(ir), triglycerides, waist circumference), and immune (white blood cell count, C-reactive protein) markers. We fit Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CI) of overall cancer mortality risk, according to quartiles (q) of the index. In multivariable models, compared to those in q1, q4 had a 64% increased risk for cancer mortality (HR = 1.64, 95% CI:1.13–2.40). The immune domain drove the association (HR per unit = 1.19, 95% CI:1.07–1.32). In stratified analyses, the HR for those with a BMI ≥ 25 was 1.12 per unit (95% CI:1.05–1.19) and those with a BMI < 25 was 1.04 per unit (95% CI:0.92–1.18). MSBR is positively associated with risk for cancer mortality in a US sample, particularly among those who are overweight or obese. The utilization of standard clinical measures comprising this index may inform population cancer prevention strategies.
format Online
Article
Text
id pubmed-7081240
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70812402020-03-23 Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study Acheampong, Teofilia Jiang, Luohua Ziogas, Argyrios Odegaard, Andrew O. Sci Rep Article Multi-systemic biological risk (MSBR), a proxy for allostatic load, is a composite index of biomarkers representing dysregulation due to responses to chronic stress. This study examined the association of an MSBR index with cancer mortality. The sample included n = 13,628 adults aged 20–90 from the NHANES III Linked Mortality File (1988–1994). The MSBR index included autonomic (pulse rate, blood pressure), metabolic (HOMA(ir), triglycerides, waist circumference), and immune (white blood cell count, C-reactive protein) markers. We fit Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CI) of overall cancer mortality risk, according to quartiles (q) of the index. In multivariable models, compared to those in q1, q4 had a 64% increased risk for cancer mortality (HR = 1.64, 95% CI:1.13–2.40). The immune domain drove the association (HR per unit = 1.19, 95% CI:1.07–1.32). In stratified analyses, the HR for those with a BMI ≥ 25 was 1.12 per unit (95% CI:1.05–1.19) and those with a BMI < 25 was 1.04 per unit (95% CI:0.92–1.18). MSBR is positively associated with risk for cancer mortality in a US sample, particularly among those who are overweight or obese. The utilization of standard clinical measures comprising this index may inform population cancer prevention strategies. Nature Publishing Group UK 2020-03-19 /pmc/articles/PMC7081240/ /pubmed/32193496 http://dx.doi.org/10.1038/s41598-020-61945-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Acheampong, Teofilia
Jiang, Luohua
Ziogas, Argyrios
Odegaard, Andrew O.
Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study
title Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study
title_full Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study
title_fullStr Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study
title_full_unstemmed Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study
title_short Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study
title_sort multi-systemic biological risk and cancer mortality: the nhanes iii study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081240/
https://www.ncbi.nlm.nih.gov/pubmed/32193496
http://dx.doi.org/10.1038/s41598-020-61945-9
work_keys_str_mv AT acheampongteofilia multisystemicbiologicalriskandcancermortalitythenhanesiiistudy
AT jiangluohua multisystemicbiologicalriskandcancermortalitythenhanesiiistudy
AT ziogasargyrios multisystemicbiologicalriskandcancermortalitythenhanesiiistudy
AT odegaardandrewo multisystemicbiologicalriskandcancermortalitythenhanesiiistudy